The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., et al. (1997) · Nature · doi:10.1038/40187 · Cited by 2,859
Rho GTPases and their effector proteins
BISHOP, A. L., & HALL, A. (2000) · Biochemical Journal · doi:10.1042/bj3480241 · Cited by 2,575
Rho GTPases and signaling networks
Van Aelst, L., & D’Souza-Schorey, C. (1997) · Genes & Development · doi:10.1101/gad.11.18.2295 · Cited by 2,358
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Self-citationPrescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Self-citationBurridge, K., & Wennerberg, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00003-0 · Cited by 1,578
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Self-citationStatins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase
Laufs, U., & Liao, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24266 · Cited by 1,035 · cited 1×
“The mechanism is owing to inhibition of RhoA geranylgeranylation, alteration of the cytoskeleton and localization of the eNOS mRNA [75].”
BackgroundSelf-citationHeme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Circulating and Tissue Endothelin Immunoreactivity in Advanced Atherosclerosis
Lerman, A., Edwards, B. S., Hallett, J. W., Heublein, D. M., Sandberg, S. M., & Burnett, J. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110033251404 · Cited by 953
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 818
Brouilette, S. W., Moore, J. S., McMahon, A. D., Thompson, J. R., Ford, I., Shepherd, J., Packard, C. J., & Samani, N. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60071-3 · Cited by 745
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 1×
“Furthermore, oxLDL can also recruit leukocytes to the arterial wall and activates NF-κB, a major proinflammatory transcription factor that is crucial for the induction of vascular cell adhesion molecule (VCAM)-1 and monocyte chemotactic protein (MCP)-1 [67].”
BackgroundStatin therapy and autoimmune disease: from protein prenylation to immunomodulation
Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1839 · Cited by 683
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Sudhop, T., Lütjohann, D., Kodal, A., Igel, M., Tribble, D. L., Shah, S., Perevozskaya, I., & von Bergmann, K. (2002) · Circulation · doi:10.1161/01.cir.0000034044.95911.dc · Cited by 682
(1984) · JAMA · doi:10.1001/jama.251.3.365 · Cited by 643
Pahan, K., Sheikh, F. G., Namboodiri, A. M., & Singh, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119812 · Cited by 571
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 542
Regulation of NADPH Oxidases: The Role of Rac Proteins
Hordijk, P. L. (2006) · Circulation Research · doi:10.1161/01.res.0000204727.46710.5e · Cited by 525
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 491
Self-citationSytkowski, P. A., Kannel, W. B., & D'Agostino, R. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222304 · Cited by 489
Regulation of reactive-oxygen-species generation in fibroblasts by Rac 1
SUNDARESAN, M., YU, Z.-X., FERRANS, V. J., SULCINER, D. J., GUTKIND, S., IRANI, K. J., GOLDSCHMIDT-CLERMONT, P. J., & FINKEL, T. (1996) · Biochemical Journal · doi:10.1042/bj3180379 · Cited by 486
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J., Rizzo, M., & Singh, I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16205-3 · Cited by 469
Shibuya, M., Suzuki, Y., Sugita, K., Saito, I., Sasaki, T., Takakura, K., Nagata, I., Kikuchi, H., Takemae, T., Hidaka, H., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.4.0571 · Cited by 466
Landmesser, U., Bahlmann, F., Mueller, M., Spiekermann, S., Kirchhoff, N., Schulz, S., Manes, C., Fischer, D., de Groot, K., Fliser, D., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164260.82417.3f · Cited by 425
Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., Ichiki, T., Takahashi, S., & Takeshita, A. (2003) · Circulation Research · doi:10.1161/01.res.0000096650.91688.28 · Cited by 418
Node, K., Fujita, M., Kitakaze, M., Hori, M., & Liao, J. K. (2003) · Circulation · doi:10.1161/01.cir.0000084539.58092.de · Cited by 414
Self-citationAir Force/Texas Coronary Atherosclerosis Prevention Study
佐々木, 淳. (2008) · Japanese journal of clinical medicine · Cited by 411
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407
Assmus, B., Urbich, C., Aicher, A., Hofmann, W. K., Haendeler, J., Rössig, L., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2003) · Circulation Research · doi:10.1161/01.res.0000070067.64040.7c · Cited by 392
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Self-citationModulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis
Sordella, R., Jiang, W., Chen, G.-C., Curto, M., & Settleman, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00271-x · Cited by 384
Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., & Boisvert, W. A. (2002) · Circulation Research · doi:10.1161/01.res.0000018941.10726.fa · Cited by 356
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Konkol, C., Sauer, H., Böhm, M., & Nickenig, G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12257-2 · Cited by 345
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
Horwich, T. B., MacLellan, W. R., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.049 · Cited by 341
Juan, S.-H., Lee, T.-S., Tseng, K.-W., Liou, J.-Y., Shyue, S.-K., Wu, K. K., & Chau, L.-Y. (2001) · Circulation · doi:10.1161/hc3801.095663 · Cited by 331
Werns, S. W., Walton, J. A., Hsia, H. H., Nabel, E. G., Sanz, M. L., & Pitt, B. (1989) · Circulation · doi:10.1161/01.cir.79.2.287 · Cited by 322
Essig, M., Nguyen, G., Prié, D., Escoubet, B., Sraer, J.-D., & Friedlander, G. (1998) · Circulation Research · doi:10.1161/01.res.83.7.683 · Cited by 316
Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure
Go, A. S., Lee, W. Y., Yang, J., Lo, J. C., & Gurwitz, J. H. (2006) · JAMA · doi:10.1001/jama.296.17.2105 · Cited by 291
Simvastatin Induces Heme Oxygenase-1: A Novel Mechanism of Vessel Protection
Lee, T.-S., Chang, C.-C., Zhu, Y., & Shyy, J. Y.-J. (2004) · Circulation · doi:10.1161/01.cir.0000140694.67251.9c · Cited by 266
Laufs, U., Endres, M., Custodis, F., Gertz, K., Nickenig, G., Liao, J. K., & Böhm, M. (2000) · Circulation · doi:10.1161/01.cir.102.25.3104 · Cited by 265
Self-citationTavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Janssens, S., Flaherty, D., Nong, Z., Varenne, O., van Pelt, N., Haustermans, C., Zoldhelyi, P., Gerard, R., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.97.13.1274 · Cited by 239
ToddBourcier, & PeterLibby (2000) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 233
Greenwood, J., Walters, C. E., Pryce, G., Kanuga, N., Bemud, E., Baker, D., & Adamson, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1014fje · Cited by 227
Bourcier, T., & Libby, P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.556 · Cited by 222
Inhibition of Rho-Kinase Attenuates Hypoxia-Induced Angiogenesis in the Pulmonary Circulation
Hyvelin, J.-M., Howell, K., Nichol, A., Costello, C. M., Preston, R. J., & McLoughlin, P. (2005) · Circulation Research · doi:10.1161/01.res.0000174287.17953.83 · Cited by 207
Decreased Perivascular Fibrosis but Not Cardiac Hypertrophy in ROCK1 +/− Haploinsufficient Mice
Rikitake, Y., Oyama, N., Wang, C.-Y. C., Noma, K., Satoh, M., Kim, H.-H., & Liao, J. K. (2005) · Circulation · doi:10.1161/circulationaha.105.584623 · Cited by 205
Self-citationLima, J. A. C., Desai, M. Y., Steen, H., Warren, W. P., Gautam, S., & Lai, S. (2004) · Circulation · doi:10.1161/01.cir.0000145170.22652.51 · Cited by 196
Hunninghake, D. B. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199202000-00005 · Cited by 195
Sawada, N., Itoh, H., Ueyama, K., Yamashita, J., Doi, K., Chun, T.-H., Inoue, M., Masatsugu, K., Saito, T., Fukunaga, Y., et al. (2000) · Circulation · doi:10.1161/01.cir.101.17.2030 · Cited by 195
Hernández-Perera, O., Pérez-Sala, D., Soria, E., & Lamas, S. (2000) · Circulation Research · doi:10.1161/01.res.87.7.616 · Cited by 188
Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease
Nohria, A., Grunert, M. E., Rikitake, Y., Noma, K., Prsic, A., Ganz, P., Liao, J. K., & Creager, M. A. (2006) · Circulation Research · doi:10.1161/01.res.0000251668.39526.c7 · Cited by 170
Self-citationLiao, J. K., Bettmann, M. A., Sandor, T., Tucker, J. I., Coleman, S. M., & Creager, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.4.1027 · Cited by 165
Self-citationTowards Complete Sets of Farnesylated and Geranylgeranylated Proteins
Maurer-Stroh, S., Koranda, M., Benetka, W., Schneider, G., Sirota, F. L., & Eisenhaber, F. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030066 · Cited by 162
Rho-Associated Protein Kinase Contributes to Early Atherosclerotic Lesion Formation in Mice
Mallat, Z., Gojova, A., Sauzeau, V., Brun, V., Silvestre, J.-S., Esposito, B., Merval, R., Groux, H., Loirand, G., & Tedgui, A. (2003) · Circulation Research · doi:10.1161/01.res.0000099062.55042.9a · Cited by 161
KJEKSHUS, J. K., Dunselman, P., Blideskog, M., Eskilson, C., Hjalmarson, Å. C., McMurray, J. J. V., Waagstein, F., Wedel, H., Wessman, P., & Wikstrand, J. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.09.005 · Cited by 159
Yang, Z., Krasnici, N., & Lüscher, T. F. (1999) · Circulation · doi:10.1161/01.cir.100.1.5 · Cited by 158
Statins and Mortality Among Elderly Patients Hospitalized With Heart Failure
Foody, J. M., Shah, R., Galusha, D. H., Masoudi, F. A., Havranek, E. P., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.105.591446 · Cited by 152
Katsumata, N., Shimokawa, H., Seto, M., Kozai, T., Yamawaki, T., Kuwata, K., Egashira, K., Ikegaki, I., Asano, T., Sasaki, Y., et al. (1997) · Circulation · doi:10.1161/01.cir.96.12.4357 · Cited by 152
Gregg, D., Rauscher, F. M., & Goldschmidt‐Clermont, P. J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2003 · Cited by 145
Fichtlscherer, S., Schmidt‐Lucke, C., Bojunga, S., Rössig, L., Heeschen, C., Dimmeler, S., & Zeiher, A. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi881 · Cited by 140
Ichiki, T., Takeda, K., Tokunou, T., Iino, N., Egashira, K., Shimokawa, H., Hirano, K., Kanaide, H., & Takeshita, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.099430 · Cited by 130
Statin Use and Survival Outcomes in Elderly Patients With Heart Failure
Ray, J. G., Gong, Y., Sykora, K., & Tu, J. V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.62 · Cited by 123
Perspectives in Cholesterol-Lowering Therapy
Bruckert, É., Giral, P., & Tellier, P. (2003) · Circulation · doi:10.1161/01.cir.0000072345.98581.24 · Cited by 112
Plasminogen Activator Inhibitor Type-1 in Cardiovascular Disease
Huber, K., Christ, G., Wojta, J., & Gulba, D. C. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00293-6 · Cited by 102
Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic Stiffness
Noma, K., Goto, C., Nishioka, K., Jitsuiki, D., Umemura, T., Ueda, K., Kimura, M., Nakagawa, K., Oshima, T., Chayama, K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.082 · Cited by 101
Self-citationTherapeutic potential of lovastatin in multiple sclerosis
Sena, A., Pedrosa, R., & Morais, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1070-8 · Cited by 96
Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone
Piorkowski, M., Fischer, S., Stellbaum, C., Jaster, M., Martus, P., Morguet, A. J., Schultheiss, H., & Rauch, U. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.064 · Cited by 93
Aprahamian, T. R., Bonegio, R. G. B., Rizzo, J. L., Perlman, H., Lefer, D. J., Rifkin, I. R., & Walsh, K. X. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3028 · Cited by 93
Nishiyama, T., Kii, I., & Kudō, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403546200 · Cited by 88
Dendritic cells: New roles for Cdc42 and Rac in antigen uptake?
Nobes, C. D., & Marsh, M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00736-3 · Cited by 81
Liao, J. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99973-4 · Cited by 72
Self-citationPlasminogen Activator Inhibitor Type-1 (PAI-1) and its Role in Cardiovascular Disease
Peter, K., Ruef, J., Kübler, W., Bode, C., & Nordt, T. K. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615546 · Cited by 71
Farah, S., Agazie, Y. M., Ohan, N. W., Ngsee, J. K., & Liu, X. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4740 · Cited by 70
Mukai, Y., Wang, C.-Y., Rikitake, Y., & Liao, J. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00868.2006 · Cited by 63
Self-citationDifferential Modulation of Caveolin-1 Expression in Cells of the Vasculature by Statins
Plenz, G. A. M., Hofnagel, O., & Robenek, H. (2004) · Circulation · doi:10.1161/01.cir.0000111128.83347.7a · Cited by 47
Statin therapy in Alzheimer's disease
Kivipelto, M., Solomon, A., & Winblad, B. G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70150-2 · Cited by 43
Xu, C., Stenman, E., & Edvinsson, L. I. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01189-9 · Cited by 33
Cholesterol lowering and coronary artery disease: mechanisms of risk reduction
Archbold, A., & Timmis, A. (1998) · Heart · doi:10.1136/hrt.80.6.543 · Cited by 22
みどり子, 東. (2004) · Medical Entomology and Zoology · Cited by 18
Cited by
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Immunity, atherosclerosis and cardiovascular disease
Frostegård, J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-117 · Cited by 1,040
Morphological integration and developmental modularity
Klingenberg, C. P. (2008) · Annual Review of Ecology Evolution and Systematics · doi:10.1146/annurev.ecolsys.37.091305.110054 · Cited by 863
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567
Self-citationKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Metadata
- Authors
- Wang, C.-Y., Liu, P.-Y., & Liao, J. K.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 14
- Issue
- 1
- Pages
- 37-44
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1982283178
- Cited by
- 593
- References
- 108
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.